Navigation Links
Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting
Date:6/1/2009

.com

  1. MacVicar G, et al. An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with castrate resistant prostate cancer (CRPC). Abstract #5062; Poster Board #17; Poster Discussion, May 31, 8:00 a.m.-12:00 p.m.
  2. Poiesz B, et al. Preliminary report of an open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with docetaxel refractory prostate cancer. Abstract #5145; Poster Board #J13; GU General Poster Session, May 31, 2:00 p.m.-6:00 p.m.
  3. Fiveash J, et al. NABT-0702: A phase II study of AT-101 in recurrent glioblastoma multiforme (GBM). Abstract #2010; Poster Board #2; Poster Discussion, May 30, 8:00 a.m.-12:00 p.m.
  4. Ready N, et al. AT-101 or placebo (P) with docetaxel (D) in second line NSCLC with gene signature biomarker development. Abstract #3577; Poster Board #J19; Developmental Therapeutics, May 30, 8:00 a.m.-12:00 p.m.
  5. Heist R, et al. A phase I/II study of AT-101 in combination with topotecan (T) in patients with relapsed or refractory small cell lung cancer (SCLC) after prior platinum containing first line chemotherapy. Abstract #8106; Poster Board #R14; Lung Cancer - Metastatic, May 30, 2:00 p.m.-6:00 p.m.


'/>"/>
SOURCE Ascenta Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
4. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
7. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
8. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
9. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
10. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
11. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 Veridiam (www.veridiam.com) won ...any category at the 2009 Workplace Excellence Awar...ety for Human Resources Management and recognize i...s. ,, Veridiam was one of nine winners, selecte... honored at the recent awards ceremony. San Diego-...
(Date:11/20/2009)...TTLER TOLEDO recently announced that a free webina...Using At-Line Particle Characterization”, wi...nar, the application of in situ particle character...d optimize a series of roller compaction runs whil...mpaction forces. , (PRWEB...
(Date:11/19/2009)...ov. 19 Dr. Mate Hidvegi, inventor ...o a press release issued on November 17 by Biropha...king false and self-serving statements about its U...dvegi stated from his office in Budapest, Hungary:...mar does not apply to AveULTRA, www.aveultra.com...
(Date:11/19/2009)...ermany, November 19 MONITORING FOR... 16th, 2009 Flibanserin in the,indication treatmen...n,s,disease for orphan drug status designation wit...nduced dyskinesia is a complication of the mainsta...burden to some of those,affected, since it may be ...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...if., Oct. 11 CV Therapeutics,Inc. (Nasdaq: CVTX ...er,financial results for 2007 after the market clo...t will webcast a conference call at 4:30 p.m. EST,...s the live webcast, please log on to the Company,s...estor Information section. Alternatively,domestic ...
...ON, QC, Oct. 11 /PRNewswire-FirstCall/ - The Board... announce the appointment of,Mr. James A. Northrop...ve,November 5, 2007. A member of the Board of Dir...ed chief executive with a record of success in rap...experience in the direct selling,consumer packaged...
...ct. 11 Access Genetics, an Eden Prairie-,based mo..., announced today,that it has appointed Paul J. Ho...- Legal, Quality and Regulatory. Mr. Hoedeman was...sly,served as VP of Finance at Home Depot, CFO and...troller of NCR Corporation. He holds a J.D.,from W...
Other Biology Technology:CV Therapeutics To Announce 2007 Third Quarter Financial Results on Tuesday, November 6, 2007 2Immunotec Inc. announces appointment of President & CEO James A. Northrop 2Access Genetics Announces New Executive Appointments 2
(Date:11/20/2009)...ction of flax shives, and generated from Brassica...se which engulf fields in spring, can be used to p...studies carried out by Spanish and Dutch researche...tainable Energy Reviews . , "These studies evalua...ction of bioethanol from two, as yet unexploited s...
(Date:11/20/2009)...earch Center (ERC) has been awarded a grant from t...ods of recovering and reusing the heat that would ...sion process in a carbon capture system. The goal ...pture and sequestration, or storage (CCS), and thu...tted into the atmosphere by coal-fired power plant...
(Date:11/19/2009)...in chemical with an unwieldy name: 4-hydroxybutyra...d as a date-rape drug. , Now, a team of Ohio an...y which 4-HB is metabolized by the body. "This is ...bson, professor and chair of biological sciences a...f the research team. "It may provide new clues on...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 1Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 2Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 3Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 4Takeda Receives FDA Complete Response Letter for Alogliptin an Investigational Treatment for Type 2 Diabetes 4658 1Takeda Receives FDA Complete Response Letter for Alogliptin an Investigational Treatment for Type 2 Diabetes 4658 2Sanofi aventis Stands Behind the Safety of Lantus 28R 29 4657 1Sanofi aventis Stands Behind the Safety of Lantus 28R 29 4657 2Sanofi aventis Stands Behind the Safety of Lantus 28R 29 4657 3
...is created in this cool movie , ,Scientists at ... (NIST) have created polymer nanotubes that are un...e enough to maintain their shape indefinitely. Des...al Academy of Sciences,* the NIST nanotubes may ha... volumes of chemicals in nanofluidic reactor devic...
...stem cells given to animals that have neurological... a stroke or newborns with cerebral palsy can sign...uries, researchers say. , Using a commonly utilize...d a dose of 200,000-400,000 human stem cells into ...ant loss of mobility and other functions. The ste...
...etective work. Biology researchers at Lewis & ...ound evidence for an ancient transfer of a toxin b...-spiders and a bacterium. But the mystery remains ... Their research is published this month in the jou... titled "Lateral gene transfer of a dermonecrotic ...
Other Biology News:Stable polymer nanotubes may have a biotech future 2Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 2Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 3Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 4Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 5Evolution mystery: Spider venom and bacteria share same toxin 2
Human / Mouse / Rat Chk1 Kinase, active ELISA development Kit, DuoSet, IC (Intracellular) from R&D Systems
Bovine Serum Albumin Peroxidase Stabilizer Solution from BioFX Laboratories, Inc.
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...s an agarose-digesting enzyme isolated from Pseudo...bohydrate bonds in agarose producing carbohydrate ...rbohydrate molecules will not interfere with subse...enzyme can be used for restriction endonuclease di...
Biology Products: